pharma · Chronic Inflammatory Demyelinating Polyneuropathy · Multifocal Motor Neuropathy · DNTH
Dianthus Therapeutics, Inc
Dianthus Therapeutics, Inc. /DE/
News and analysis for Dianthus Therapeutics, Inc on NovaPharmaNews — regulatory, clinical, and market coverage.
New York City, USA HQ
111 Employees
Public company Type
DNTH · NYSE Ticker
Company details
- Status
- Public
- HQ
- New York City, USA
- Employees
- 111
- Programs
- 6
- Drugs
- 12
- Patents
- 2
News & analysis
NovaPharmaNews articles mentioning Dianthus Therapeutics, Inc — regulatory, clinical, and market coverage.
News and analysis for Dianthus Therapeutics, Inc on NovaPharmaNews — regulatory, clinical, and market coverage.